Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
Clinical trial NCT07662031 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07662031
- Sponsor
- Washington University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2030-08-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.